Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors (Q45856282)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2002

Language	Label	Description	Also known as
English	Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors	scientific article published in May 2002

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

author name string

Hui Huang

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

YongQing Liu

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

Jim Xiang

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

publication date

1 May 2002

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

Cellular Immunology

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

217

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

1-2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

12-22

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Treatment of subcutaneous tumor with adoptively transferred T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

The next frontier of molecular medicine: delivery of therapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

A new class of membrane-bound chemokine with a CX3C motif

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Mig and IP-10: CXC chemokines that target lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

A Role for the Interferon-Inducible Protein 10 in Inhibition of Angiogenesis by Interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Adenovirus-mediated TNF-alpha gene transfer induces significant tumor regression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Regression of engineered tumor cells secreting cytokines is related to a shift in host cytokine profile from type 2 to type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

How do cytotoxic lymphocytes kill their targets?

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Protein sorting and secretion during CTL killing

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900508-7

7 January 2021

Identifiers

10.1016/S0008-8749(02)00508-7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/12425997

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45856282&oldid=2086715588"